Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). - Mauriac,L.; MacGrogan,G.; Avril,A. (Ann Oncol, 1999)